A new systematic literature review has found that it may not be cost-effective to provide primary screening for chronic kidney disease (CKD) in the general population.

Continue Reading

However, primary CKD prevention screening does appear to be cost-effective in patients with diabetes and hypertension.

John Schieszer has the latest on the story in today’s Medical Minute.